1335 related articles for article (PubMed ID: 18352765)
1. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
2. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
3. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
4. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
King JA; Armstrong D; Vachhrajani S; Dirks PB
J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
[TBL] [Abstract][Full Text] [Related]
5. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
Smith ER; McClain CD; Heeney M; Scott RM
Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
[TBL] [Abstract][Full Text] [Related]
6. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
[TBL] [Abstract][Full Text] [Related]
7. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Hayashi T; Shirane R; Fujimura M; Tominaga T
J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
[TBL] [Abstract][Full Text] [Related]
8. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
Fryer RH; Anderson RC; Chiriboga CA; Feldstein NA
Pediatr Neurol; 2003 Aug; 29(2):124-30. PubMed ID: 14580655
[TBL] [Abstract][Full Text] [Related]
9. Modified encephaloduroarteriosynangiosis with bifrontal encephalogaleoperiosteal synangiosis for the treatment of pediatric moyamoya disease. Technical note.
Park JH; Yang SY; Chung YN; Kim JE; Kim SK; Han DH; Cho BK
J Neurosurg; 2007 Mar; 106(3 Suppl):237-42. PubMed ID: 17465392
[TBL] [Abstract][Full Text] [Related]
10. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
Alamri A; Hever P; Cheserem J; Gradil C; Bassi S; Tolias CM
Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
[TBL] [Abstract][Full Text] [Related]
11. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
Khan N; Schuknecht B; Boltshauser E; Capone A; Buck A; Imhof HG; Yonekawa Y
Acta Neurochir (Wien); 2003 Dec; 145(12):1061-71; discussion 1071. PubMed ID: 14663563
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
13. Moya Moya cases treated with encephaloduroarteriosynangiosis.
Tripathi P; Tripathi V; Naik RJ; Patel JM
Indian Pediatr; 2007 Feb; 44(2):123-7. PubMed ID: 17351302
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Moyamoya disease in the adult population with pial synangiosis.
Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
[TBL] [Abstract][Full Text] [Related]
15. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
16. Patients with moyamoya disease presenting with movement disorder.
Pandey P; Bell-Stephens T; Steinberg GK
J Neurosurg Pediatr; 2010 Dec; 6(6):559-66. PubMed ID: 21121731
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of one-stage direct revascularization and medicine therapy for treatment of ischemic moyamoya disease].
Zhao H; You C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Sep; 23(9):1097-100. PubMed ID: 19817297
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
